NEWS
2023-12-01 08:45
Ola Sandborgh takes office as CEO for Lipum AB today
Lipum AB (publ) is strengthening its leadership when going into phase II by appointing Ola Sandborgh as its new CEO where he takes over the helm from Einar...
2023-11-30 08:00
Lipum changes its liquidity provider to Carnegie Investment Bank AB
Lipum AB (publ) has terminated the liquidity provider assignment with Erik Penser Bank AB and has appointed Carnegie Investment Bank AB as new liquidity...
2023-11-09 13:00
Lipum appoints Ola Sandborgh as new Chief Executive Officer
Lipum (publ), a clinical stage biopharmaceutical company focused on chronic inflammatory diseases, today announced that the Board of Directors has appointed...
2023-10-31 08:00
Lipum AB – interim report for the period July-September 2023
Lipum AB (publ) has published the interim report for period July to September for 2023. Below is a summary, a complete report (only in Swedish) is available...
2023-09-13 08:45
Lipum to participate in following upcoming
Lipum (publ), a clinical stage biopharmaceutical company focused on chronic inflammatory diseases, today announced its participation in the following upcoming...
2023-08-31 08:00
Lipum AB – interim report for the period January-June 2023
Lipum AB (publ) has published the interim report for period January to June for 2023. Below is a summary, a complete report (only in Swedish) is available...
2023-08-14 07:30
PLOS ONE publishes results that highlights the role of BSSL in inflammatory joint disorders
Lipum AB (publ) today reported that the scientific publication titled “Effects of bile salt-stimulated lipase on blood cells and associations with...
2023-08-08 08:30
Lipum in collaboration with the Karolinska Institute
Lipum (publ) has entered a collaboration with researchers at the Karolinska Institute (KI), Division of Rheumatology at the Department of Medicine in Sweden...
2023-07-20 17:15
Lipum announces the final outcome of the rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA...
2023-07-18 17:45
Lipum announces the preliminary outcome of the rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA...